Plain language isn’t just for patients—it’s for HCPs too.

Clear communication isn’t just a matter of convenience or courtesy; it empowers patients to take charge of their health while building trust among healthcare professionals (HCPs). 

Put simply, plain language makes science accessible and usable. When scientific information is distilled into clear, actionable terms, it accelerates decisions and builds trust among experts. What’s more, it smooths the path for adoption of innovations—from novel diagnostics, to clinical trials, to emerging therapies. And in oncology, where every minute matters, usability can be the difference between hesitation and action.

Time is of the essence

Oncology sits at the intersection of rapidly-evolving science and essential human care. In the race for a cure, researchers publish breakthroughs at a staggering pace—including immunotherapies, biomarker-driven approaches, and next-generation sequencing. For oncologists already stretched thin by research funding, patient loads, administrative demands, and emotional toll, absorbing new information is no small feat.

Dense, jargon-laden communications only add friction. Consider the difference between two descriptions of the same test result:

• “The assay demonstrates 95% specificity and 87% sensitivity in detecting actionable genomic variants across heterogeneous tumor types.”
• “This test correctly identifies nearly all target mutations while avoiding false positives, making it reliable across many cancer types.”

Technically speaking, both blurbs are accurate. But one requires parsing and/or a deep prior knowledge, while the other gets straight to the point. Time-starved oncologists don’t need the extra cognitive load. They need clarity they can trust.

Who benefits from brevity?

1. Oncologists and Frontline HCPs –Every day, oncologists balance mountains of clinical data, evolving guidelines, and complex patient needs. When trial designs, lab reports, or new therapeutic mechanisms are communicated in plain language, decision-making gets faster. Instead of wading through technical barriers, physicians can focus on what matters: is this relevant for my patient? Does it change my treatment plan?
2. Key Opinion Leaders (KOLs) and Skeptics –Plain language also helps win over experts who are (understandably) cautious. Oncology has no shortage of promising tools that never gained traction because their value wasn’t communicated clearly. A KOL scanning a new clinical trial summary isn’t looking for marketing flair—they’re asking, Does this stand up to scrutiny? Plain language doesn’t mean leaving rigor behind; it means presenting evidence in a way that respects time, intellect, and skepticism.
3. Healthcare Systems and Decision-Makers –Adoption of new diagnostics or therapies often requires alignment across institutions, payers, and policymakers. Plain language reduces misinterpretation and accelerates buy-in. A hospital administrator doesn’t need every molecular detail of a sequencing platform—they need to know its benefits, limitations, and impact on workflow, stated clearly and confidently.

Tightening up vs. “dumbing down”

A common misconception is that plain language “dumbs down” science. In truth, it does the opposite. By stripping away unnecessary jargon and tightening complex explanations, plain language reveals the very essence of the science. It respects the audience’s intelligence while acknowledging their limited time.

Think of it as translating dense data into insight: plain language answers the so what? without erasing nuance. A well-crafted executive summary of a Phase II trial doesn’t ignore confidence intervals or endpoints—it frames them in terms of practical relevance: What was studied? What was found? Why does it matter for practice today?

The plain-language playbook

Many of the principles used to improve patient education apply equally well to HCP communication. For example, clinical trials are painstakingly designed, but their published results can be impenetrable for many. For a practicing oncologist, the essential questions are:

1. Who was studied?
2. What intervention was tested?
3. How did patients respond?
4. What were the risks?
5. How does this compare to current standards of care?

It’s crucial not to bury the lead. A trial abstract that obscures these answers in acronyms and statistical shorthand risks disengagement. But one that makes these points clear—while still linking to detailed appendices—invites both engagement and application. 

These seven pillars can help pair-down jargon for more concise, clear communication:

1. Front-load relevance. Start with the bottom line. What’s new, and why should experts care? Supporting detail can follow.
2. Use a tiered approach. Provide a concise overview for rapid scanning, with options to dive deeper into methods and data.
3. Translate statistics into meaning. Don’t just report hazard ratios—explain what they mean for survival, quality of life, or treatment choice.
4. Clarity > complexity: Short sentences and straightforward vocabulary aid faster comprehension.
5. Active voice: “The trial showed improved survival” is cleaner than “Improved survival was demonstrated by the trial.”
6. Structure and hierarchy: Headings, bullet points, and summaries help busy readers scan quickly and return later.
7. Visual aids: Diagrams, infographics, and simplified charts convey mechanisms or results at a glance.

Talking the talk

For decades, the prestige of scientific communication has been tied to its complexity. Dense writing was seen as a marker of rigor and prestige, while clarity was sometimes dismissed as “simplistic.” Plain language isn’t just for patients, and as science evolves, we can no longer afford that mindset. Lives depend on swift understanding and adoption of new science, and accessibility is an essential tool for translating innovation into action.

Patients benefit when HCPs can rapidly understand and apply new evidence. KOLs engage more deeply when data is presented clearly. Healthcare systems adopt innovations more confidently when value is stated plainly. Research teams and medical writers alike need to adopt plain language as a skill, not an afterthought.By making science easier to act on—even for those who live and breathe it—we bridge the gap between discovery and impact.